Teva Pharmaceutical Industries (NYSE:TEVA) Sees Unusual Trading Volume in Its Shares

Clal Insurance Enterprises Holdings Ltd sold 1.30 million shares as Teva Pharmaceutical Inds Ltd Adr (TEVA)’s stock declined 15.11%. Nwam LLC now owns 16,080 shares of the company’s stock worth $516,000 after buying an additional 5,674 shares during the last quarter. Strategy Asset Managers Llc who had been investing in Teva Pharmaceutical Inds Ltd for a number of months, seems to be bullish on the $16.41 billion market cap company.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) traded up 0.25% during trading on Friday, reaching $15.90. About shares traded. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since September 2, 2016 and is downtrending. It has underperformed by 11.20% the S&P500.

Rhenman & Partners Asset Management Ab, which manages about $521.63M US Long portfolio, decreased its stake in Merck & Co Inc (NYSE:MRK) by 130,000 shares to 70,000 shares, valued at $4.12 million in 2016Q4, according to the filing. Oak Ridge Investments Llc acquired 467,894 shares as Five Below (FIVE)’s stock rose 32.44%. The Oak Ridge Investments Llc holds 1.24M shares with $49.62 million value, up from 773,731 last quarter. Markel Corp now has $14.52B valuation. 131.23 million shares or 2.53% less from 134.65 million shares in 2016Q3 were reported. Hingham Institution for Savings (NASDAQ:HIFS) has risen 36.45% since September 2, 2016 and is uptrending. It has outperformed by 19.75% the S&P500.

Since March 2, 2017, it had 0 insider purchases, and 1 sale for $2.92 million activity. The stock has “Sell” rating by Zacks on Wednesday, August 12. On average, equities analysts anticipate that Teva Pharmaceutical Industries Limited will post $4.32 earnings per share for the current fiscal year.

Investors sentiment increased to 1.18 in 2016 Q4.

These funds have also shifted positions in (TEVA). Finally, Pillar Pacific Capital Management LLC raised its stake in shares of Teva Pharmaceutical Industries Limited by 10.0% in the first quarter. Daiwa Secs Gru holds 2,000 shares. Manning & Napier Advsrs Limited Liability Corporation stated it has 0.07% in Q2 Holdings Inc (NYSE:QTWO). Driehaus Mngmt Lc holds 0.4% of its portfolio in Q2 Holdings Inc (NYSE:QTWO) for 390,006 shares. Virginia-based Quantitative Invest Management Limited Liability Company has invested 0.04% in New Residential Investment Corp (NYSE:NRZ). 3,450 were reported by Toronto Dominion Bancorp. Moreover, State Street has 0% invested in Five Below Inc (NASDAQ:FIVE) for 1.32M shares. Retail Bank owns 12,490 shares or 0.01% of their USA portfolio. Suntrust Banks Inc reported 3,027 shares. Commonwealth Of Pennsylvania Pub School Empls Retrmt holds 0.02% or 7,875 shares in its portfolio.

Menora Mivtachim Holdings Ltd decreased Credit Suisse Group (NYSE:CS) stake by 60,100 shares to 56,000 valued at $802,000 in 2016Q4. Comfort Systems Usa Inc. Therefore 56% are positive. The firm has “Outperform” rating by RBC Capital Markets given on Friday, June 3. Finally, Maxim Group restated a “hold” rating and issued a $35.00 target price on shares of Teva Pharmaceutical Industries Limited in a research note on Thursday, July 13th. Equity analyst Morgan Stanley lowered the price target and downgraded the stock on August 7 cutting the price target from $42.00 to $16.00 and changing the rating from “Equal-Weight” to “Underweight”. As per Friday, February 5, the company rating was maintained by RBC Capital Markets. JMP Securities initiated the shares of NRZ in report on Wednesday, December 23 with “Mkt Outperform” rating. The rating was maintained by Canaccord Genuity with “Buy” on Friday, August 7. The firm has “Sector Perform” rating by RBC Capital Markets given on Wednesday, November 18. Four investment analysts have rated the stock with a sell rating, twenty have given a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. Therefore 50% are positive. Teva Pharma had 85 analyst reports since July 21, 2015 according to SRatingsIntel. HSBC upgraded the stock to “Buy” rating in Monday, July 18 report.

More notable recent Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) news were published by: Investorplace.com which released: “Battered Teva Pharmaceutical Industries Ltd (ADR) Stock Still Is Toxic” on August 29, 2017, also Investorplace.com with their article: “Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Not a Falling Knife …” published on August 04, 2017, Investorplace.com published: “Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Intrepid Potash, Inc …” on August 07, 2017. Cantor Fitzgerald restated a “hold” rating and set a $27.00 target price on shares of Teva Pharmaceutical Industries Limited in a research report on Wednesday. As per Tuesday, June 27, the company rating was maintained by Oppenheimer. As per Monday, August 7, the company rating was maintained by Barclays Capital.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) last announced its earnings results on Thursday, August 3rd. As per Monday, July 10, the company rating was downgraded by UBS. The rating was downgraded by Jefferies on Wednesday, November 16 to “Hold”.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *